EUVIMEDEUVIMED entdecken
Crossref

Development of Hemagglutinin–Neuraminidase Homologous Peptides as Novel Promising Therapeutic Agents Against Peste des Petits Ruminants Virus

Aditya Agrawal, Rajat Varshney, Anil Gattani, Mahvash Hira Khan, Rohini Gupta, Khushal Singh Solanki, Shailesh Kumar Patel, R P Singh, Praveen Singh

The Protein Journal · 2023

DOI: 10.1007/s10930-023-10134-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Protein Journal, 2023. Verfasst von Aditya Agrawal und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Animal Biochemistry, IVRI, Izatnagar, Bareilly, U.P., 243122, India. agrawaladitya1986@gmail.com. Hauptthemen laut MEDLINE: Peste-des-petits-ruminants virus, Antiviral Agents, Peptides, HN Protein. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: ICAR-Indian Veterinary Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The lack of specific antiviral therapy and complications associated with the existing peste des petits ruminants (PPR) vaccines accentuates the search of novel antiviral blocking agents in order to curtail the PPR infection at initial level. The synthetic hemagglutinin-neuraminidase (HN) homologous peptides may compete with the natural HN protein of PPR virus for binding to signaling lymphocytic activation molecule (SLAM) receptor, consequently, may disrupt peste des petits ruminants virus (PPRV) at entry level. Therefore, insilico analysis, synthesis, purification and subsequent characterization of HN homologous peptides were conducted in this study. The HN homologous peptides were synthesized by means of solid phase chemistry and were purified by reversed-phase-high performance liquid chromatography. The mass as well as sequence of HN homologous peptides were assessed by mass spectroscopy while its secondary structure was elucidated by circular dichroism spectroscopy. The binding (interaction) efficacy of HN homologous peptides with PPRV antibodies was assessed via indirect enzyme linked immunosorbent assay, visual detection test (red wine to purple), bathochromic shift under UV-Vis spectrophotometry and lateral flow immunochromatographic strip test. The antiviral properties and cytotoxicity of these peptides were also assessed in B95a cell line with changes in cytopathic effect and titer of PPRV (Sungri/96). The presence of green fluorescein isothiocyanate over the B95a cell surface pointed towards the binding of HN homologous peptides with surface SLAM receptor. Moreover, the intact beta sheet configuration in water and lower cytotoxicity [cytotoxic concentration 50 (CC50) > 1000 µg/ml] of these peptides signifies its in vivo use. Among HN homologous peptides, the binding efficacy and antiviral properties of pep A was relatively high in comparison to pep B and Pep ppr peptides. The prerequisite concentration of HN homologous peptides (pep A = 12.5 µg/ml; pep B = 25 µg/ml; pep ppr = 25 µg/ml) to exemplify its antiviral effect was much lower than its CC50 level. Hence, this study signifies the therapeutic potential of synthetic HN homologous peptides.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peste-des-petits-ruminants virusAntiviral AgentsPeptidesHN ProteinPeste-des-Petits-RuminantsAnimalsCell Line

Stichwörter der Autor:innen

Antiviral peptidesCD spectroscopyHN homologous peptidesPPRVSLAM receptor

Substanzen

Antiviral AgentsPeptidesHN Protein

Autor:innen und Institutionen

  • Division of Animal Biochemistry, IVRI, Izatnagar, Bareilly, U.P., 243122, India. agrawaladitya1986@gmail.com.
  • Department of Veterinary Physiology and Biochemistry, College of Veterinary Science and Animal husbandry, NDVSU, Rewa, Jabalpur, 486001, India. agrawaladitya1986@gmail.com.
  • Department of Veterinary Microbiology, BHU, Mirzapur, U.P., 231001, India.
  • Division of Bacteriology and Mycology, IVRI, Izatnagar, Bareilly, U.P., 243122, India.
  • Division of Animal Biochemistry, IVRI, Izatnagar, Bareilly, U.P., 243122, India.
  • Department of Veterinary Physiology and Biochemistry, College of Veterinary Science and Animal husbandry, NDVSU, Jabalpur, 486001, India.

Förderung

  • ICAR-Indian Veterinary Research Institute

Zitieren

APA

Agrawal, A., Varshney, R., Gattani, A., Hira Khan, M., Gupta, R., Solanki, K. S., Patel, S. K., Singh, R. P., & Singh, P. (2023). Development of Hemagglutinin–Neuraminidase Homologous Peptides as Novel Promising Therapeutic Agents Against Peste des Petits Ruminants Virus. The Protein Journal. https://doi.org/10.1007/s10930-023-10134-4

Vancouver

Agrawal A, Varshney R, Gattani A, Hira Khan M, Gupta R, Solanki KS, et al. Development of Hemagglutinin–Neuraminidase Homologous Peptides as Novel Promising Therapeutic Agents Against Peste des Petits Ruminants Virus. The Protein Journal. 2023. doi:10.1007/s10930-023-10134-4

BibTeX
@article{Agrawal2023,
  author = {Agrawal, Aditya and Varshney, Rajat and Gattani, Anil and Hira Khan, Mahvash and Gupta, Rohini and Solanki, Khushal Singh and Patel, Shailesh Kumar and Singh, R P and Singh, Praveen},
  title = {Development of Hemagglutinin–Neuraminidase Homologous Peptides as Novel Promising Therapeutic Agents Against Peste des Petits Ruminants Virus},
  journal = {The Protein Journal},
  year = {2023},
  doi = {10.1007/s10930-023-10134-4}
}
Kostenlos starten →